| Article | Added |
|---|
| The June 2012 Issue of The Burrill Report | 05-18-12 |
| European Private Investment Fundraising Up 80 Percent | 05-18-12 |
| Military Veterans Support Alternative Fuels | 05-18-12 |
| Kythera Files to Go Public Under JOBS Act | 05-18-12 |
| International Doctors' Group Criticizes Gates? Global Vaccines Plan | 05-18-12 |
| Express Scripts Settles Employee Theft Charges | 05-18-12 |
| Trial Seeks to Stop Alzheimer's before it Starts | 05-18-12 |
| Agilent Acquires Dako for $2.2 Billion | 05-18-12 |
| International Doctor's Group Criticizes Gates? Global Vaccines Plan | 05-18-12 |
| Osiris Wins Canadian Approval for World's First Stem Cell Drug | 05-18-12 |
| Approvals of Innovative Drugs by FDA Surpass EU, Canada | 05-18-12 |
| A Venture Investor Cries Mea Culpa | 05-18-12 |
| Blech, One-Time "King of Biotech," Pleaded Guilty to Manipulating Stock Prices | 05-11-12 |
| Gilead's Truvada Gains Support for HIV Prevention | 05-11-12 |
| Daiichi Sankyo Enters Biosimilars Arena with Coherus BioSciences | 05-11-12 |
| Groups Weigh in on Biosimilars | 05-11-12 |
| Vertex's Cystic Fibrosis Considered ?Game-Changer? | 05-11-12 |
| Bayer Appeals Forced Licensing in India | 05-11-12 |
| Use of Avastin for Eye Disease Could Save NHS $136 Million Annually | 05-11-12 |
| User Fee Deal Eased Some Burdens, Exacerbated Others, Report Says | 05-11-12 |
| GSK Goes Hostile | 05-12-12 |
| Keeping Score at the FDA | 05-11-12 |
| VCs See Sharp Drop in Biotech Investment | 05-04-12 |
| Investor Groups to Help Laid-Off Merck KGaA Employees Form Spin-offs | 05-04-12 |
| NIH Seeks to Find Uses for Shelved Compounds | 05-04-12 |
| Piecing Together the Proteome | 05-04-12 |
| Friction for Pharma Abroad, But Progress Too | 05-04-12 |
| How to Fix Life Sciences IPOs | 05-04-12 |
| Hedge Fund Attacks Savient Over Financials | 05-04-12 |
| Castlight Health Secures another $100 Million in a Series D Financing | 05-04-12 |
| Protalix Approval a Win for Its Manufacturing Technology | 05-04-12 |
| Takeda Fails to Win FDA Approval for Diabetes Drug | 04-26-12 |
| Buyouts Catch Fire in Race for Global Market Share | 04-26-12 |
| Tackling Oral Cancer with a Smartphone | 04-27-12 |
| FDA's Woodcock Argues for Clinical Research Makeover | 04-28-12 |
| Saying | 04-27-12 |
| AstraZeneca CEO to Step Down | 04-27-12 |
| P2P Healthcare and the Portals of Power | 04-27-12 |
| Takeda Fails to Win FDA Approval for Diabetes Drug Alogliptin as Actos Faces Patent Expiration | 04-26-12 |
| Saying "No" to an IPO | 04-27-12 |
| NIH grants $10.5 Million for Genome Explorations | 04-27-12 |
| Novartis Challenging Avastin Use for Eye Disease in the U.K. | 04-23-12 |
| AstraZeneca Agrees to Buy Ardea Biosciences for $1.3 Billion | 04-24-12 |
| FDA Stretches to Go Global | 04-23-12 |
| NICE Rejects Avastin for Breast Cancer | 04-20-12 |
| Health IT Deals Hot in Q1 | 04-19-12 |
| GlaxoSmithKline Steers toward Innovation | 04-20-12 |
| Survey: One in Four Americans Had a Gap in Healthcare Coverage in 2011 | 04-20-12 |
| The May 2012 Issue of The Burrill Report | 04-20-12 |
| Generic Drugmakers Score Victory at Supreme Court | 04-20-12 |
| Endocyte Scores with Merck Partnership | 04-20-12 |
| Race for All-Oral Treatment for Hep C Leaps Forward | 04-19-12 |
| Roche Decides Against Extending Offer for Illumina | 04-20-12 |
| Funding Early-Stage Companies with Radical Technologies | 04-20-12 |
| Amgen to Buy KAI Pharmaceuticals | 04-13-12 |
| J&J Fined $1.1 Billion For Deceptive Marketing | 04-13-12 |
| Takeda Acquires URL Pharma in $800 Million Deal | 04-13-12 |
| Drug Shortages and the Role of the Middle Man | 04-13-12 |
| Berwick Says Billions Can Be Saved through Cutting Waste | 04-13-12 |
| R&D Spending for Drug Giants Drops to $49.5 Billion in 2011 | 04-13-12 |
| Mayo Clinic launches whole genome breast cancer study | 04-13-12 |
| Roche Hints at Negotiating Room in Illumina Bid | 04-14-12 |
| U.S. Should Tax Medical Services to Fund Public Health, Says IOM | 04-13-12 |
| What's Ahead for Biotech Stocks | 04-13-12 |
| BARDA Cuts Funding for Radiation Poisoning Treatment | 04-06-12 |
| Covidien Looks to Israel for Novel Medical Devices | 04-06-12 |
| New Report Finds Prescription Drug Spending Flat | 04-06-12 |
| US Unveils $200 Million Big Data Initiative | 04-06-12 |
| GE Expands Diagnostic Business with SeqWright Buy | 04-06-12 |
| Predictive Value of Whole Genome Sequencing Questioned | 04-06-12 |
| Amgen and AstraZeneca to Collaborate on Inflammation Portfolio | 04-06-12 |
| Following Late-Stage Failure, Spectrum To Buy Allos | 04-06-12 |
| GAO Sees Gloomy Fiscal Outlook without Health Reform | 04-06-12 |
| Forging a Launch Pad for Emerging Growth IPOs | 04-06-12 |
| US Protests India's Compulsory License for Nexavar | 03-30-12 |
| Nanotech Armor Guards Against Breast Cancer Remission | 03-30-12 |
| FDA Approves Affymax Anemia Therapy | 03-30-12 |
| New Guidelines on Taking Life's Measure | 03-30-12 |
| Bausch & Lomb to Buy Ista Pharmaceuticals | 03-31-12 |
| Celtic Launches ADC Therapeutics with $50 Million | 03-31-12 |
| Chelsea Therapeutics? Falls on FDA Rejection of Northera | 03-30-12 |
| Understanding the Shifting Patent Landscape | 03-30-12 |
| Merrimack IPO Falls Out the Gate | 03-30-12 |
| How Free Agents are Reshaping the Life Sciences | 03-22-12 |
| The April 2012 Issue of The Burrill Report | 03-27-12 |
| Roche and Illumina Duke It out Ahead of Annual Meeting | 03-24-12 |
| Groups Seek Congressional Action on Drug Shortages | 03-23-12 |
| JNJ Faces Flood of Lawsuits for Unauthorized Medical Device | 03-23-12 |
| MediVector Lands $138.5 Million Defense Contract | 03-23-12 |
| Unauthorized Distribution of Medical Device Leads to 550 Lawsuits | 03-23-12 |
| AstraZeneca and Targacept Won?t Seek Approval for Depression Drug | 03-23-12 |
| Daily Dose of Aspirin Reduces Risk of Cancer | 03-23-12 |
| Supreme Court Ruling Creates Uncertainty for Diagnostics Companies | 03-23-12 |
| Senate Passes IPO On-Ramp Bill | 03-23-12 |
| Wellcome Trust launches $317 million investment fund | 03-23-12 |
| Wellcome Trust launches $316 million investment fund | 03-23-12 |
| Healthcare Reform Gets Its Day in Court | 03-22-12 |
| Shire Surprisingly Pulls Biologics License Application | 03-16-12 |
| Biogen Idec Looks Ahead on MS | 03-16-12 |
| Asahi Kasei Expands in Healthcare with $2.2 Billion Zoll Medical Buy | 03-16-12 |
| Pfizer Ends $350 Million Insulin Pact | 03-16-12 |
| Boston Scientific Connects With Vodafone for Cardiac Monitoring | 03-16-12 |
| Shire Buys FerroKin BioSciences for $325 Million | 03-16-12 |
| An iPOPping Result | 03-16-12 |
| India Orders Bayer to License Nexavar | 03-16-12 |
| Merck Commits $90 Million to Found Drug Discovery Center | 03-16-12 |
| California Cigarette Tax Could Ignite Cancer Research | 03-16-12 |
| The Single Biggest Opportunity to Improve Health Outcomes | 03-09-12 |
| Gilead Falls on News of Additional Hep C Patients Relapsing | 03-09-12 |
| Hospital Quality Reporting Program Had Little Impact on Death Rates | 03-09-12 |
| Cost of Drugs Rockets Past Inflation, Says AARP | 03-09-12 |
| J&J Impresses with Prostate Cancer Drug | 03-09-12 |
| Boston Scientific to Acquire Cameron Health for Up to $1.4B | 03-09-12 |
| Alzheimer's Costs to Top $200 Billion a Year | 03-10-12 |
| Novartis Takes Glivec Arguments to India's Supreme Court | 03-09-12 |
| Working Out at Starbucks | 03-09-12 |
| Joint Venture Seeks to Bring Medical Innovation to Russia | 03-09-12 |
| Boston Scientific to Acquire Cameron Health for Up to $1.35B | 03-09-12 |
| Joint Custody | 03-02-12 |
| Bribery a Growing Legal Liability for Big Pharma, says Reuters | 03-01-12 |
| Galapagos Scores with Abbott Deal | 03-01-12 |
| Shire Inks Antibody Discovery Alliance with arGEN-X | 03-02-12 |
| NIH Takes Its Genetic Testing Registry Online | 03-01-12 |
| CMS Tries Text Messaging to Improve Health for New Moms | 03-02-12 |
| FDA Adds New Warnings to Statin Labels | 03-02-12 |
| Biogen and Samsung Advance Biosimilars Venture | 03-01-12 |
| Dainippon Sumitomo to Acquire Boston Biomedical | 03-02-12 |
| Court Rules New FDA Labels for Cigarettes Unconstitutional | 03-02-12 |
| The Long Journey from the Amazon to the FDA | 03-01-12 |
| Borscht Belt | 02-24-12 |
| Intent Dissent | 02-23-12 |
| Hepatitis C Remains A Hot Play | 02-23-12 |
| Patients Sue U.S. Agencies Over Drug Shortages | 02-24-12 |
| Coming Together | 02-24-12 |
| FDA Panel Recommends Approval of New Obesity Drug | 02-24-12 |
| Pfizer and Hisun Near Joint Venture Pact | 02-24-12 |
| Myriad Case Heads to Court of Public Opinion | 02-24-12 |
| A Push for Accelerated Approvals | 02-23-12 |
| The March 2012 Issue of The Burrill Report | 02-22-12 |
| Proposed FDA Budget Leans on Industry | 02-17-12 |
| Gilead Drops on Poor Clinical Trials Results of Pharmasset Drug | 02-17-12 |
| Rusnano Invests in Novel Diagnostics | 02-17-12 |
| Despite Cuts, Big Pharma Says It's Still Overstaffed | 02-17-12 |
| Amyris Scales Back | 02-17-12 |
| FDA's 2013 Budget Leans on Industry for Boost | 02-17-12 |
| Biogen Idec Commits Up to $487.5M to Acquire Stromedix | 02-17-12 |
| Feds Recoup $4.1 Billion in Healthcare Fraud | 02-17-12 |
| Will Obama's Budget Hinder Innovation? | 02-16-12 |
| The Sinews of Safety | 02-09-12 |
| Obama Administration Boosts Alzheimer's Research Spending | 02-10-12 |
| FDA Unveils Biosimilars Guidance | 02-10-12 |
| Medical Device Firms Bring In the Bucks | 02-10-12 |
| Siemens Seeks Growth in Companion Diagnostics | 02-10-12 |
| Astex Pharma Plummets after Advisory Panel Rejects the Use of Dacogen for Cancer | 02-10-12 |
| Can the FDA Get California's Biotech Sector Growing Again? | 02-10-12 |
| Yesterday's Science Fiction, Tomorrow's Reality | 02-10-12 |
| U.S. Lagging in Science and Technology Education | 02-10-12 |
| Obama Administration Boosts Research Spending on Alzheimer's | 02-10-12 |
| GSK Boast: Improving R&D Productivity | 02-10-12 |
| Developing Countries Lead Adoption Rate of Biotech Crops | 02-10-12 |
| Americans Warming to Healthcare Reform Law | 02-02-12 |
| E-Prescriptions Could Improve Patient Adherence | 02-03-12 |
| Drug Supplies and Economics 101 | 02-03-12 |
| Big Pharma Declares War on Neglected Diseases | 02-03-12 |
| Two Life Sciences IPOs Debut Below Target | 02-03-12 |
| Medical Device Makers Trade Higher Fees Faster Review Times | 02-03-12 |
| FDA, Industry Urge Quick Passage of User Fee Renewal | 02-03-12 |
| Federal Spending on Healthcare to Double by 2022 | 02-03-12 |
| AstraZeneca Axes 7,300 Jobs, 12 Percent of Workforce | 02-03-12 |
| Fixing Drug Development with the Wisdom of Crowds | 02-04-12 |
| Big Biotech Fuels M&A Activity | 01-27-12 |
| Hitting the Target | 01-26-12 |
| Infinity Pharmaceuticals Tanks on Failed Cancer Drug Trial | 01-27-12 |
| Gates Gives Global Fund $750 Million Boost | 01-27-12 |
| Novo to Launch Type 1 Diabetes R&D Center | 01-27-12 |
| The Physician Payment Sunshine Act: More Darkness Than Light | 01-27-12 |
| Kaiser Connects Patients on the Go | 01-27-12 |
| Strategic Outsourcing To Buoy European Drug Manufacturers | 01-27-12 |
| What's Driving Roche's $5.7 Billion Bid for Illumina | 01-27-12 |
| US Obesity Rates Hold Steady | 01-20-12 |
| Sanofi Scientist Pleads Guilty to Thefts | 01-20-12 |
| Pfizer, Medivation End Development of Alzheimer's Drug | 01-20-12 |
| Proteus Debuts Smart Pill in the United Kingdom | 01-20-12 |
| Mobile Health App Revenue Perks Up | 01-20-12 |
| Renewable Energy Group IPO Prices Well Below Target Range | 01-20-12 |
| Can Pharma Cure its Social Anxiety Disorder? | 01-20-12 |
| Janssen's San Diego Experiment | 01-20-12 |
| Panel Drafts Audacious Plan to Combat Alzheimer's Disease | 01-20-12 |
| Proteus Debuts Smart Pill in the United Kindom | 01-20-12 |
| Russian Scientist Say Siberian Bacteria May Slow Aging | 01-20-12 |
| Can Pharma Cures Its Social Anxiety Disorder | 01-20-12 |
| The February 2012 Issue of The Burrill Report | 01-19-12 |
| Novartis to Ax 2,000 jobs after Tekturna Development Halted | 01-13-12 |
| Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact | 01-13-12 |
| Forma Therapeutics Inks Alliance with Janssen Biotech | 01-13-12 |
| Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion | 01-12-12 |
| Flagship Ventures Launches $270 Million Fund | 01-12-12 |
| Drugs in Bugs | 01-13-12 |
| Cutting Healthcare Spending with Occam's Razor | 01-13-12 |
| Why Regenerative Medicine Might Fix Healthcare | 01-12-12 |
| Medtronic Scores Digital Health Victory | 01-06-12 |
| Smith & Nephew and Essex Woodlands Form Joint Venture | 01-06-12 |
| Forma Cuts $815 Million Deal with Boehringer to Discover New Cancer Drugs | 01-05-12 |
| Record Drug Shortages Plagued the Year Gone By | 01-06-12 |
| Medtronic Launches Wireless Glucometer | 01-06-12 |
| Biogen Idec and Isis Partner on Rare Spinal Disorder | 01-06-12 |
| Costs of Off-label Marketing of Anti-Psychotic Grow for J&J | 01-06-12 |
| Teva Names A New CEO | 01-06-12 |
| Pharma ? Guide Thyself | 01-06-12 |
| Biotech Investors Get Their War Face On for JPMorgan | 01-05-12 |
| Deals for the Week Ending December 30, 2011 | 12-30-11 |
| Fundraising in 2011 | 12-30-11 |
| Genentech: The Beginnings of Biotech | 12-30-11 |
| Takeda acquires Intellikine for $310M | 12-22-11 |
| Even the Insured Forgo Care | 12-23-11 |
| Ranbaxy will pay $500 million to settle issues with FDA | 12-23-11 |
| Metamark and Janssen Partner on Cancer | 12-22-11 |
| Widely-Used Estimate of Costs to Develop Drug May Be Conservative | 12-22-11 |
| DOJ Recovers Billions in Fraudulent Healthcare Charges | 12-22-11 |
| Pharma's Incredibly Shrinking R&D Budget | 12-22-11 |
| Filling the Funding Gap | 12-22-11 |
| Amgen and Watson Enter Biosimilars Collaboration | 12-22-11 |
| The January 2012 Issue of The Burrill Report | 12-20-11 |
| Combining Talents to Fund Early Stage Companies | 12-16-11 |
| Quintiles Launches China CRO | 12-16-11 |
| Abbott Licenses Reata Pipeline for $400M | 12-16-11 |
| Amgen CEO and Research Chief to Step Down | 12-16-11 |
| AstraZeneca Strikes Pact with UK Medical Research Council | 12-16-11 |
| SEC Charges Stiefel Labs and its Former CEO with Fraud | 12-16-11 |
| Congress Axes Rule that Restricted Innovation Funding | 12-16-11 |
| Healthcare Reform Extends Coverage to 2.5M Young Adults | 12-16-11 |
| BioSante's "Female Viagra" Fails Late-Stage Trials | 12-16-11 |
| Venture Investors Grow Grim | 12-16-11 |
| Merck Outlines $1.5 Billion Commitment to Expand R&D in China | 12-09-11 |
| Pharmacyclics Scores Big with Janssen Biotech Deal | 12-09-11 |
| Kessler: Bayer Obscured Risks of Contraceptive | 12-09-11 |
| UK Government Touts Plans for Boosting Drug Development | 12-09-11 |
| Nursing Workforce Sees Surge in Young Aged Entrants | 12-09-11 |
| Samsung and Biogen Idec Form $300 Million Joint Venture | 12-09-11 |
| Qualcomm Formalizes Wireless Health Fund | 12-09-11 |
| Sebelius Blocks OTC Sales of Morning After Pill to Adolescents | 12-09-11 |
| Diagnostics Deals Heat Up | 12-08-11 |
| New Bill Designed to Make IPOs Welcoming to Emerging Growth Companies | 12-01-11 |
| Affymetrix Will Pay $330 Million to Acquire eBioscience | 12-02-11 |
| Obama Appoints New CMS Chief | 12-02-11 |
| UK's NICE Nixes Novartis? Lucentis for Diabetic Macular Edema | 12-02-11 |
| Supreme Court Takes On Drug Rep Pay Case | 12-02-11 |
| AstraZeneca Adds $100 Million to MedImmune Ventures | 12-02-11 |
| Senators Question Pfizer's Lipitor Deals | 12-02-11 |
| Amgen Issued New Patent on RA Drug Enbrel | 12-01-11 |
| Why Pfizer Might Have Been Better Off Without Lipitor | 12-01-11 |
| Portola Brings in Cash to Advance Anticoagulant | 11-22-11 |
| Regeneron Challenges Genentech's Lucentis | 11-23-11 |
| Rich Market Unfolds for Mobile Health in Asia | 11-22-11 |
| Merck pays $950M to Settle Vioxx Criminal and Civil Settlement | 11-23-11 |
| CVS Strikes Back at Co-Pay Coupons | 11-23-11 |
| Will Alnylam's Results Reignite Fervor for RNAi | 11-23-11 |
| Pharma's R&D Costs Soar as Returns Fall | 11-22-11 |
| Health Network Kicks Into High Gear | 11-22-11 |
| Gilead Agrees to Buy Pharmasset for $11 Billion | 11-22-11 |
| Healthcare Companies Lobby To Avoid Cuts | 11-22-11 |
| Talking Turkey About Access to Medicines | 11-22-11 |
| Biotechs Rake in the Cash in Mid-Stage Rounds | 11-17-11 |
| Doctor Who Faked Drug Research Permanently Debarred | 11-17-11 |
| Pfizer Cuts Lipitor Deals to Fight Generics | 11-17-11 |
| The Need for Speed | 11-17-11 |
| Canada Commits $58 Million to Genomics | 11-18-11 |
| FDA Revokes Avastin Approval in Breast Cancer | 11-18-11 |
| Where have all the VC's Gone? | 11-17-11 |
| New Survey Finds Care is Often Poorly Coordinated | 11-17-11 |
| Supreme Court to Review Healthcare Law | 11-16-11 |
| Geron Dumps Stem Cells for Cancer Focus | 11-16-11 |
| WuXi Forms $50 Million Venture Fund | 11-16-11 |
| The December 2011 Issue of The Burrill Report | 11-14-11 |
| NewLink Genetics Goes Public | 11-11-11 |
| Amylin and Lilly Part Ways on Byetta | 11-11-11 |
| Former Shanghai Pharmaceutical Exec Gets Suspended Death Sentence | 11-11-11 |
| Suicide Switch | 11-11-11 |
| China's Largest Biotech Plans IPO | 11-10-11 |
| Antibiotic Prescriptions for Kids Extremely Common and Frequently Inappropriate | 11-10-11 |
| Embracing Risk as We Embrace Benefit | 11-10-11 |
| The Ultimate Exit Strategy | 11-10-11 |
| Obama's Healthcare Legislation Ruled Constitutional | 11-10-11 |
| A Mississippi Victory as the Battle Over Stem Cell Research Rages on | 11-10-11 |
| A Novel Approach to Funding a Startup | 11-04-11 |
| GSK Reaches $3 Billion Settlement with U.S. Over Criminal and Civil Investigations | 11-04-11 |
| Biggest Market Movers | 11-04-11 |
| Proposed Indian Pricing Scheme Could Slash Prices on Foreign Drugs | 11-04-11 |
| Mayo Researchers Look to Exploit Measles to Treat Cancer | 11-04-11 |
| Sanofi Set to Pass Pfizer as Biggest Drug Company | 11-04-11 |
| Encouraging Data Sends Medivation Soaring | 11-04-11 |
| Pfizer's and Teva's Results Point to Shifting Demand | 11-04-11 |
| Payment Disclosure Rules Still Unclear | 11-04-11 |
| Seeking to End Drug Shortages | 11-04-11 |
| What A Growing and Aging World Mean for Healthcare | 11-04-11 |
| Biotech's Access to Capital Difficult in Volatile Economic Times | 10-28-11 |
| Biotie Therapeutics Breaks Off Plans to Buy Newron Pharmaceuticals | 10-28-11 |
| Targeted Therapeutics Get a Russian Boost | 10-28-11 |
| Common Asthma Drugs May Boost Health Risk for Children | 10-27-11 |
| Same Fight, New Ring | 10-26-11 |
| BGI Establishes West Coast Beachhead with UC Davis Deal | 10-27-11 |
| Molecular Diagnostics Makers Face Tougher Standards for Payment | 10-26-11 |
| Cigna Agrees to Acquire HealthSpring for $3.8 Billion | 10-26-11 |
| Novartis Trims Workforce to Fit a Changing World | 10-26-11 |
| Roche Makes Germans an Offer It Hopes They Can?t Refuse | 10-26-11 |
| Chinese National Pleads Guilty to Espionage | 10-21-11 |
| Zeltiq's Debut Breaks Life Science IPO Doldrums | 10-20-11 |
| AMAG Shareholders Reject Acquisition of Allos | 10-21-11 |
| EU High Court Bans Embryonic Stem Cell Patents | 10-21-11 |
| Roche Buys Anadys for $230M | 10-21-11 |
| Abbott to Split into Two Independent Public Companies | 10-21-11 |
| U.S. Health Care System Scores Poorly on National Scorecard | 10-21-11 |
| Virtual Care Center, Venture Funds Support Telehealth Efforts | 10-21-11 |
| Looking for Reassurance at the BIO Investor Forum | 10-20-11 |
| DNAnexus Nails $15M Venture Investment from Google and TPG | 10-16-11 |
| GlycoMimetics Inks Deal with Pfizer for Rare Disease Drug | 10-13-11 |
| Researchers Correct Sickle Cell Disease in Mice | 10-14-11 |
| Medical Device Developers Attract Cash | 10-14-11 |
| NICE Says Cost of Bristol-Myers Melanoma Drug Too High | 10-13-11 |
| The November 2011 Issue of The Burrill Report | 10-14-11 |
| Europe Warned on Slow Pace of GM Crop Approvals | 10-13-11 |
| Bayer Launches $860 Million Joint Venture with Russia's Yunona Holdings | 10-14-11 |
| Can California Protect a Bright Source of Job Growth | 10-13-11 |
| Planning for Wild Success | 10-13-11 |
| Et tu, Pharma? | 10-06-11 |
| Blame it on the FDA | 10-06-11 |
| Contract Researcher PPD Goes Private | 10-06-11 |
| Thriving in the Data Deluge | 10-07-11 |
| Former Cougar Biotechnology CEO Seeks to Repeat Success with Puma | 10-07-11 |
| Illumina Falls on Disappointing Sales | 10-06-11 |
| FDA Outlines Innovation Plan | 10-06-11 |
| Avastin Loses Insurer Support in California | 10-06-11 |
| Sing for Your Supper | 10-06-11 |
| German Law Has Companies Weighing Whether to Sell New Drugs In Europe's Largest Market | 10-06-11 |
| Commonality Vs. Conflict | 10-03-11 |
| Oxygen Biotherapeutics Says Former CEO Allegedly Falsified Resume, Abused Post | 09-30-11 |
| Cleveland BioLabs Enters Into a Joint Venture with Rusnano | 09-30-11 |
| Teva Acquires Control of Teva-Kowa Joint Venture | 09-30-11 |
| BARDA Steps Up Awards for Radiation Countermeasures | 09-30-11 |
| DOJ asks Supreme Court Review of the Affordable Care Act | 09-30-11 |
| Death Panels, Talk Radio, and Unplugging Grandma | 09-30-11 |
| Drug Shortage Clipping Clinical Trials | 09-30-11 |
| Boehringer Jumps Into Biosimilars | 09-30-11 |
| A Tough Road for Health IT Innovators | 09-30-11 |
| Pressures on Medtech Forcing New Approaches | 09-30-11 |
| Biorenewables Makers File to Go Public | 09-23-11 |
| Hua Medicine Lands $50 Million to Finance Its Biotech Activities | 09-23-11 |
| Pac Bio Slashes Staff Fearing Slower-Than Expected Adoption Because of the Bad Economy | 09-23-11 |
| Obesity Drugmakers Gain New Traction with FDA | 09-23-11 |
| GE Establishes Joint Venture in Russia | 09-23-11 |
| VA Stops Using Avastin for Eyes, Boosting Prospects for Regeneron Drug | 09-23-11 |
| Report Says Non-communicable Diseases Pose Threat to Economic Health | 09-22-11 |
| Deficit Reduction Could Pain Biotech | 09-22-11 |
| GE Establishes Two Joint Ventures in Russia | 09-22-11 |
| What Patent Reform Means for Biotech | 09-22-11 |
| Playing a Video Game Like Life is on the Line | 09-21-11 |
| NIH Initiatives Boost Biotech | 09-21-11 |
| Teva Pharmaceuticals Strengthens Its Innovation Pipeline | 09-15-11 |
| A Sweet Sponge Becomes a Familiar Villain | 09-15-11 |
| Genzyme Must Ration Cerezyme--Again | 09-16-11 |
| New $100M Challenge Fund Seeks to Spark Cancer Innovation | 09-16-11 |
| Global Diabetes Epidemic Continues to Rise | 09-15-11 |
| Public Misreads the Meaning of FDA Approval | 09-15-11 |
| Pro Bono Bio Melds East and West | 09-15-11 |
| Express Scripts-Medco Deal Gets Another Going-Over | 09-15-11 |
| Patient, Know Thyself | 09-15-11 |
| Sharing the Responsibility | 09-15-11 |
| A Sweet Sponge Becomes a Familiar Villian | 09-15-11 |
| Pushing Policies in a Changed Washington | 09-15-11 |
| The October 2011 Issue of The Burrill Report | 09-14-11 |
| BARDA Funds Bioterror Countermeasures | 09-09-11 |
| Roche and Evotec Enter Alzheimer's Licensing Pact | 09-08-11 |
| Aurobindo Pharma Expands into Russia | 09-08-11 |
| Dendreon to Slash 500 Jobs as Part of Restructuring | 09-08-11 |
| Excess Weight as Young Adult Predicts Earlier Death | 09-09-11 |
| Merck Serono Raises Bet on F-Star | 09-08-11 |
| Eisai Taps Outside Funding | 09-08-11 |
| Sanofi Projects Growth Despite Challenges | 09-08-11 |
| GPhA's New CEO Faces a Range of Challenges | 09-08-11 |
| U.S. Investment in Health Research Remains Stagnant | 09-08-11 |
| MedImmune Sues Abbott Alleging Breach of Contract | 08-25-11 |
| Sanofi Ventures into Nutraceuticals in India | 08-25-11 |
| Sequencing Tumors to Target Treatments | 08-25-11 |
| NIH Awards $25 Million to Leverage Genetics with EHRs | 08-25-11 |
| Pfizer Wins Approval for New Lung Cancer Drug | 08-26-11 |
| Personalized Cancer Center Gets $30 Million Kick Start | 08-25-11 |
| Doctors May Need Extra Convincing on Biosimilars | 08-25-11 |
| Digital Health Startups Attract Venture Bucks | 08-26-11 |
| Pulling Together to Cut Costs | 08-26-11 |
| FTC Reviews Impact of Authorized Generics | 09-02-11 |
| Secondary Financings Dry Up | 09-02-11 |
| What the Market's Turmoil Means for Biotech Stocks | 08-26-11 |
| NuPathe Loses Half Its Market Cap after FDA Rejects Pain Patch | 09-02-11 |
| GI Dynamics completes IPO in Australia | 09-02-11 |
| Taking Cancer Detection Where It's Needed Most | 09-02-11 |
| Indian Pharma in the Spotlight | 09-02-11 |
| FDA and Industry Find Common Ground on New Rules | 09-02-11 |
| Wild Swings of Market in August Rough Up Life Sciences IPOs | 09-02-11 |
| A Look at the Surge in FDA Approvals | 09-02-11 |
| Dirty Laundry at the Hospital | 09-02-11 |
| Drug Shortages Need Addressing Now | 08-18-11 |
| IPO Class of 2011 Takes Drubbing | 08-13-11 |
| Startups Continue to Attract Venture Backing | 08-12-11 |
| Adventrx Tumbles on FDA's Rejection of Drug | 08-11-11 |
| Med Device Industry Balks at IOM Advice to FDA | 08-11-11 |
| Study Finds 29 New Genetic Variants Tied to MS | 08-11-11 |
| Russia Gets Innovative | 08-11-11 |
| The August 2011 Issue of The Burrill Report | 08-11-11 |
| Fraud and Errors Fuel Research Journal Retractions | 08-10-11 |
| Two Shots Are Better Than One | 08-10-11 |
| Pfizer Expands Academic Alliances in California | 08-08-11 |
| Government Backs Off Pursuit of Forest CEO | 08-08-11 |
| Biggest Movers for the Week Ending August 5, 2011 | 08-02-11 |
| NICE Rejects Novartis Oral MS Drug in Draft Guidance | 08-04-11 |
| New Tax Credits for Biotechs Proposed | 08-05-11 |
| Celgene and Acceleron Expand Their Collaboration | 08-05-11 |
| Dendreon Shares Plummet on Weak Provenge Sales | 08-04-11 |
| Smoking, Eating, and Drinking Beyond Their Years | 08-05-11 |
| WellDoc Rings Up Success with Diabetes Management App | 08-05-11 |
| M&A Spells Disaster for R&D | 08-05-11 |
| Shionogi Moves into China | 08-04-11 |
| Covance CEO Sees Integration Challenges For Competition | 08-05-11 |
| Doctors Say They Are Ill-Prepared for Personalized Medicine | 08-04-11 |
| Dendreon Shares Plummet, Forcing Cutbacks | 08-04-11 |
| Biggest Movers for the Week Ending July 29, 2011 | 08-02-11 |
| Merck to Cut Up to 13,000 Jobs by 2015 | 07-29-11 |
| Cloud Control | 07-29-11 |
| Horizon Pharma Goes Public | 07-29-11 |
| Boston Scientific Plans China Expansion | 07-29-11 |
| Big Pharma's Falling R&D Investment Helps Small Biotechs | 07-29-11 |
| Gene Patents Upheld in Myriad Appeal | 07-29-11 |
| Different Take on Cancer Suggests Early Chance for Prevention | 07-29-11 |
| Government Wins Stem Cell Victory | 07-29-11 |
| U.S. Healthcare Spending to Hit $4.6 Trillion by 2020 | 07-29-11 |
| Getting the Prevent Defense to Pay Off | 07-29-11 |
| Getting the Prevent Defense Pay Off | 07-29-11 |
| Government Wins Stem Cell Victory in the Courts | 07-29-11 |
| How Big Pharma's Falling R&D Investment is Helping Small Biotechs | 07-29-11 |
| Can the Prevent Defense Pay Off | 07-29-11 |
| Express Scripts finds a match in $29.1 Billion deal to buy Medco | 07-22-11 |
| M&A in a Risk-Sharing Environment | 07-22-11 |
| Merck Establishes Joint Venture with Simcere Pharmaceuticals | 07-22-11 |
| Sanofi Halts Trial of Key Drug as Regulators Examine Adverse Events | 07-22-11 |
| Venture Investment Surges in Life Sciences | 07-23-11 |
| Study Finds Disease Modifying MS Drug Too Costly | 07-22-11 |
| What I Did on My Summer Vacation | 07-22-11 |
| Halting a Brain Drain | 07-22-11 |
| Defining When a Medical App is a Regulated App | 07-22-11 |
| The July 2011 Issue of The Burrill Report | 07-20-11 |
| Project Runway | 07-20-11 |
| FDA Issues Draft Guidance on Mobile Medical Apps | 07-20-11 |
| Novartis Eyes Potential Chinese IPO | 07-16-11 |
| Innate Pharma Lands Major Collaboration with BMS | 07-08-11 |
| Amgen Tries Micromet's BiTE | 07-15-11 |
| Hot Tea and Coffee Could Fight MRSA | 07-14-11 |
| Supply of Essential Medicines Falls Short in U.S. Hospitals | 07-15-11 |
| FDA Delivers Blow to Transcept Over Insomnia Drug | 07-15-11 |
| Astellas Bets $35M on Vical Vaccine | 07-15-11 |
| FDA Wants Companion Diagnostics Approved with Paired Drugs | 07-15-11 |
| Unlocking Health Trends in 140 Characters | 07-15-11 |
| Expanding Personalized Medicine in Psychiatry | 07-15-11 |
| Debt Fight Snares Pharmaceutical Pricing | 07-14-11 |
| TPG Capital Takes Immucor Private for $1.97B | 07-08-11 |
| Innate Pharma Lands Major Collaboration with Bristol-Myers Squibb | 07-08-11 |
| Blame innovation! | 07-08-11 |
| Heart Failure Drug Natrecor Found To Be Ineffective | 07-08-11 |
| E-prescribing Is Not Error Free | 07-08-11 |
| Better Together | 07-07-11 |
| Ensuring QB3 Innovation Creates Jobs | 07-07-11 |
| Nearing the Home Stretch | 07-07-11 |
| Vigilance Pays Off | 07-07-11 |
| Study Raises Concerns About New Risks From Actos and Avandia | 06-27-11 |
| Comparative Effectiveness Research Brings Industry to a Defining Moment | 06-30-11 |
| Capital Flows to Massachusetts Startups | 07-01-11 |
| A Billion-Dollar | 06-30-11 |
| Mutually Beneficial | 06-27-11 |
| Gene Therapy Awaiting FDA Greenlight to Begin HIV Trial | 07-01-11 |
| Comparative Effectiveness Researach Brings Industry to a Defining Moment | 06-30-11 |
| A Billion-Dollar "No" Vote for Genentech | 06-30-11 |
| China Renews Commitment to Biotechnology | 06-29-11 |
| Genentech Options Forma's Preclinical Cancer Program | 06-28-11 |
| Stormy Weather | 06-27-11 |
| Google Shutters Health Records Site | 06-27-11 |
| GSK to Pay $40.8 Million to Settle Case Over Puerto Rico Plant | 06-22-11 |
| Tesaro Secures $101 Million in Venture Capital | 06-23-11 |
| Doing What It Takes?Or Not | 06-23-11 |
| Vermont Law Blocking Prescription Data Mining Overturned | 06-23-11 |
| Abbott makes $85 Million Bet on Biotest | 06-23-11 |
| Analysis of FDA Data Shows Average Review Time Up | 06-23-11 |
| FDA Surveys Import Risks | 06-23-11 |
| Venture Capitalists Say IPO Activity Levels Too Low | 06-23-11 |
| A Rare Disease Pioneer Scores $45 Million for New Company | 06-23-11 |
| Tout Tweets | 06-22-11 |
| WHO Knows | 06-17-11 |
| J&J Exiting Drug-Eluting Stent Market | 06-17-11 |
| Merck Strikes Biosimilars Deal with Hanhwa | 06-17-11 |
| Merck Strikes Biosimilars Deal with Hanwa | 06-17-11 |
| Should FDA Stand for Fast Drug Approvals? | 06-17-11 |
| Startup Snags Big Biotech Partner | 06-17-11 |
| NIH Expands Support for Translational Research | 06-17-11 |
